Tyson Kim
Chief Executive Officer bei SYNTEKABIO, INC.
Aktive Positionen von Tyson Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNTEKABIO, INC. | Chief Executive Officer | 01.01.2015 | - |
Radexel Co. Ltd.
 Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Chief Executive Officer | - | - |
Karriereverlauf von Tyson Kim
Statistik
International
| Südkorea | 3 |
Operativ
| Chief Executive Officer | 2 |
Sektoral
| Technology Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNTEKABIO, INC. | Technology Services |
| Private Unternehmen | 1 |
|---|---|
Radexel Co. Ltd.
Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Health Technology |
